Table of Contents

Global Nasopharyngeal Cancer Drug Market Research Report 2026
1 Industry Overview of Nasopharyngeal Cancer Drug
    1.1 Definition and Specifications of Nasopharyngeal Cancer Drug
        1.1.1 Definition of Nasopharyngeal Cancer Drug
        1.1.2 Specifications of Nasopharyngeal Cancer Drug
    1.2 Classification of Nasopharyngeal Cancer Drug
        1.2.1 BGBA-317
        1.2.2 CBT-501
        1.2.3 Apatinib
        1.2.4 APG-1387
        1.2.5 ARGX-110
        1.2.6 ATA-129
        1.2.7 Others
    1.3 Applications of Nasopharyngeal Cancer Drug
        1.3.1 Hospital
        1.3.2 Clinic
        1.3.3 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 Europe
        1.4.3 China
        1.4.4 Japan
        1.4.5 Southeast Asia
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Nasopharyngeal Cancer Drug
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Nasopharyngeal Cancer Drug
    2.3 Manufacturing Process Analysis of Nasopharyngeal Cancer Drug
    2.4 Industry Chain Structure of Nasopharyngeal Cancer Drug

3 Technical Data and Manufacturing Plants Analysis of Nasopharyngeal Cancer Drug
    3.1 Capacity and Commercial Production Date of Global Nasopharyngeal Cancer Drug Major Manufacturers
    3.2 Manufacturing Plants Distribution of Global Nasopharyngeal Cancer Drug Major Manufacturers
    3.3 R&D Status and Technology Source of Global Nasopharyngeal Cancer Drug Major Manufacturers
    3.4 Raw Materials Sources Analysis of Global Nasopharyngeal Cancer Drug Major Manufacturers

4 Global Nasopharyngeal Cancer Drug Overall Market Overview
    4.1 E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 E Global Nasopharyngeal Cancer Drug Capacity and Growth Rate Analysis
        4.2.2  Nasopharyngeal Cancer Drug Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 E Global Nasopharyngeal Cancer Drug Sales and Growth Rate Analysis
        4.3.2  Nasopharyngeal Cancer Drug Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 E Global Nasopharyngeal Cancer Drug Sales Price
        4.4.2  Nasopharyngeal Cancer Drug Sales Price Analysis (Company Segment)

5 Nasopharyngeal Cancer Drug Regional Market Analysis
    5.1 North America Nasopharyngeal Cancer Drug Market Analysis
        5.1.1 North America Nasopharyngeal Cancer Drug Market Overview
        5.1.2 North America E Nasopharyngeal Cancer Drug Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America E Nasopharyngeal Cancer Drug Sales Price Analysis
        5.1.4 North America  Nasopharyngeal Cancer Drug Market Share Analysis
    5.2 Europe Nasopharyngeal Cancer Drug Market Analysis
        5.2.1 Europe Nasopharyngeal Cancer Drug Market Overview
        5.2.2 Europe E Nasopharyngeal Cancer Drug Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 Europe E Nasopharyngeal Cancer Drug Sales Price Analysis
        5.2.4 Europe  Nasopharyngeal Cancer Drug Market Share Analysis
    5.3 China Nasopharyngeal Cancer Drug Market Analysis
        5.3.1 China Nasopharyngeal Cancer Drug Market Overview
        5.3.2 China E Nasopharyngeal Cancer Drug Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 China E Nasopharyngeal Cancer Drug Sales Price Analysis
        5.3.4 China  Nasopharyngeal Cancer Drug Market Share Analysis
    5.4 Japan Nasopharyngeal Cancer Drug Market Analysis
        5.4.1 Japan Nasopharyngeal Cancer Drug Market Overview
        5.4.2 Japan E Nasopharyngeal Cancer Drug Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Japan E Nasopharyngeal Cancer Drug Sales Price Analysis
        5.4.4 Japan  Nasopharyngeal Cancer Drug Market Share Analysis
    5.5 Southeast Asia Nasopharyngeal Cancer Drug Market Analysis
        5.5.1 Southeast Asia Nasopharyngeal Cancer Drug Market Overview
        5.5.2 Southeast Asia E Nasopharyngeal Cancer Drug Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Southeast Asia E Nasopharyngeal Cancer Drug Sales Price Analysis
        5.5.4 Southeast Asia  Nasopharyngeal Cancer Drug Market Share Analysis
    5.6 India Nasopharyngeal Cancer Drug Market Analysis
        5.6.1 India Nasopharyngeal Cancer Drug Market Overview
        5.6.2 India E Nasopharyngeal Cancer Drug Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India E Nasopharyngeal Cancer Drug Sales Price Analysis
        5.6.4 India  Nasopharyngeal Cancer Drug Market Share Analysis

6 Global E Nasopharyngeal Cancer Drug Segment Market Analysis (by Type)
    6.1 Global E Nasopharyngeal Cancer Drug Sales by Type
    6.2 Different Types of Nasopharyngeal Cancer Drug Product Interview Price Analysis
    6.3 Different Types of Nasopharyngeal Cancer Drug Product Driving Factors Analysis
        6.3.1 BGBA-317 Growth Driving Factor Analysis
        6.3.2 CBT-501 Growth Driving Factor Analysis
        6.3.3 Apatinib Growth Driving Factor Analysis
        6.3.4 APG-1387 Growth Driving Factor Analysis
        6.3.5 ARGX-110 Growth Driving Factor Analysis
        6.3.6 ATA-129 Growth Driving Factor Analysis
        6.3.7 Others Growth Driving Factor Analysis

7 Global E Nasopharyngeal Cancer Drug Segment Market Analysis (by Application)
    7.1 Global E Nasopharyngeal Cancer Drug Consumption by Application
    7.2 Different Application of Nasopharyngeal Cancer Drug Product Interview Price Analysis
    7.3 Different Application of Nasopharyngeal Cancer Drug Product Driving Factors Analysis
        7.3.1 Hospital of Nasopharyngeal Cancer Drug Growth Driving Factor Analysis
        7.3.2 Clinic of Nasopharyngeal Cancer Drug Growth Driving Factor Analysis
        7.3.3 Others of Nasopharyngeal Cancer Drug Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Nasopharyngeal Cancer Drug
    8.1 Ambrx Inc
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Ambrx Inc  Nasopharyngeal Cancer Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Ambrx Inc  Nasopharyngeal Cancer Drug Business Region Distribution Analysis
    8.2 arGEN-X BV
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 arGEN-X BV  Nasopharyngeal Cancer Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 arGEN-X BV  Nasopharyngeal Cancer Drug Business Region Distribution Analysis
    8.3 Atara Biotherapeutics Inc
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Atara Biotherapeutics Inc  Nasopharyngeal Cancer Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Atara Biotherapeutics Inc  Nasopharyngeal Cancer Drug Business Region Distribution Analysis
    8.4 AVEO Pharmaceuticals Inc
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 AVEO Pharmaceuticals Inc  Nasopharyngeal Cancer Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 AVEO Pharmaceuticals Inc  Nasopharyngeal Cancer Drug Business Region Distribution Analysis
    8.5 BeiGene Ltd
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 BeiGene Ltd  Nasopharyngeal Cancer Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 BeiGene Ltd  Nasopharyngeal Cancer Drug Business Region Distribution Analysis
    8.6 BioDiem Ltd
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 BioDiem Ltd  Nasopharyngeal Cancer Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 BioDiem Ltd  Nasopharyngeal Cancer Drug Business Region Distribution Analysis
    8.7 Biomics Biotechnologies Co Ltd
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Biomics Biotechnologies Co Ltd  Nasopharyngeal Cancer Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Biomics Biotechnologies Co Ltd  Nasopharyngeal Cancer Drug Business Region Distribution Analysis
    8.8 Bristol-Myers Squibb Company
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Bristol-Myers Squibb Company  Nasopharyngeal Cancer Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Bristol-Myers Squibb Company  Nasopharyngeal Cancer Drug Business Region Distribution Analysis
    8.9 CBT Pharmaceuticals Inc
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 CBT Pharmaceuticals Inc  Nasopharyngeal Cancer Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 CBT Pharmaceuticals Inc  Nasopharyngeal Cancer Drug Business Region Distribution Analysis
    8.10 Celgene Corp
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Celgene Corp  Nasopharyngeal Cancer Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Celgene Corp  Nasopharyngeal Cancer Drug Business Region Distribution Analysis
    8.11 Cell Medica Ltd
    8.12 F. Hoffmann-La Roche Ltd
    8.13 GlaxoSmithKline Plc

9 Development Trend of Analysis of Nasopharyngeal Cancer Drug Market
    9.1 Global Nasopharyngeal Cancer Drug Market Trend Analysis
        9.1.1 Global 2018-2025 Nasopharyngeal Cancer Drug Market Size (Volume and Value) Forecast
        9.1.2 Global 2018-2025 Nasopharyngeal Cancer Drug Sales Price Forecast
    9.2 Nasopharyngeal Cancer Drug Regional Market Trend
        9.2.1 North America 2018-2025 Nasopharyngeal Cancer Drug Consumption Forecast
        9.2.2 Europe 2018-2025 Nasopharyngeal Cancer Drug Consumption Forecast
        9.2.3 China 2018-2025 Nasopharyngeal Cancer Drug Consumption Forecast
        9.2.4 Japan 2018-2025 Nasopharyngeal Cancer Drug Consumption Forecast
        9.2.5 Southeast Asia 2018-2025 Nasopharyngeal Cancer Drug Consumption Forecast
        9.2.6 India 2018-2025 Nasopharyngeal Cancer Drug Consumption Forecast
    9.3 Nasopharyngeal Cancer Drug Market Trend (Product Type)
    9.4 Nasopharyngeal Cancer Drug Market Trend (Application)

10 Nasopharyngeal Cancer Drug Marketing Type Analysis
    10.1 Nasopharyngeal Cancer Drug Regional Marketing Type Analysis
    10.2 Nasopharyngeal Cancer Drug International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Nasopharyngeal Cancer Drug by Region
    10.4 Nasopharyngeal Cancer Drug Supply Chain Analysis

11 Consumers Analysis of Nasopharyngeal Cancer Drug
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Nasopharyngeal Cancer Drug Market Professional Survey Report
    Methodology
    Analyst Introduction
    Data Source
List of Tables and Figures
    Figure Picture of Nasopharyngeal Cancer Drug
    Table Product Specifications of Nasopharyngeal Cancer Drug
    Table Classification of Nasopharyngeal Cancer Drug
    Figure Global Production Market Share of Nasopharyngeal Cancer Drug by Type in
    Figure BGBA-317 Picture
    Table Major Manufacturers of BGBA-317
    Figure CBT-501 Picture
    Table Major Manufacturers of CBT-501
    Figure Apatinib Picture
    Table Major Manufacturers of Apatinib
    Figure APG-1387 Picture
    Table Major Manufacturers of APG-1387
    Figure ARGX-110 Picture
    Table Major Manufacturers of ARGX-110
    Figure ATA-129 Picture
    Table Major Manufacturers of ATA-129
    Figure Others Picture
    Table Major Manufacturers of Others
    Table Applications of Nasopharyngeal Cancer Drug
    Figure Global Consumption Volume Market Share of Nasopharyngeal Cancer Drug by Application in
    Figure Hospital Examples
    Table Major Consumers in Hospital
    Figure Clinic Examples
    Table Major Consumers in Clinic
    Figure Others Examples
    Table Major Consumers in Others
    Figure Market Share of Nasopharyngeal Cancer Drug by Regions
    Figure North America Nasopharyngeal Cancer Drug Market Size (Million USD) (2013-2025)
    Figure Europe Nasopharyngeal Cancer Drug Market Size (Million USD) (2013-2025)
    Figure China Nasopharyngeal Cancer Drug Market Size (Million USD) (2013-2025)
    Figure Japan Nasopharyngeal Cancer Drug Market Size (Million USD) (2013-2025)
    Figure Southeast Asia Nasopharyngeal Cancer Drug Market Size (Million USD) (2013-2025)
    Figure India Nasopharyngeal Cancer Drug Market Size (Million USD) (2013-2025)
    Table Nasopharyngeal Cancer Drug Raw Material and Suppliers
    Table Manufacturing Cost Structure Analysis of Nasopharyngeal Cancer Drug in
    Figure Manufacturing Process Analysis of Nasopharyngeal Cancer Drug
    Figure Industry Chain Structure of Nasopharyngeal Cancer Drug
    Table Capacity and Commercial Production Date of Global Nasopharyngeal Cancer Drug Major Manufacturers
    Table Manufacturing Plants Distribution of Global Nasopharyngeal Cancer Drug Major Manufacturers
    Table R&D Status and Technology Source of Global Nasopharyngeal Cancer Drug Major Manufacturers
    Table Raw Materials Sources Analysis of Global Nasopharyngeal Cancer Drug Major Manufacturers
    Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Nasopharyngeal Cancer Drug E
    Figure Global E Nasopharyngeal Cancer Drug Market Size (Volume) and Growth Rate
    Figure Global E Nasopharyngeal Cancer Drug Market Size (Value) and Growth Rate
    Table E Global Nasopharyngeal Cancer Drug Capacity and Growth Rate
    Table  Global Nasopharyngeal Cancer Drug Capacity (K Pcs) List (Company Segment)
    Table E Global Nasopharyngeal Cancer Drug Sales (K Pcs) and Growth Rate
    Table  Global Nasopharyngeal Cancer Drug Sales (K Pcs) List (Company Segment)
    Table E Global Nasopharyngeal Cancer Drug Sales Price (USD/Pcs)
    Table  Global Nasopharyngeal Cancer Drug Sales Price (USD/Pcs) List (Company Segment)
    Figure North America Capacity Overview
    Table North America Supply, Import, Export and Consumption (K Pcs) of Nasopharyngeal Cancer Drug E
    Figure North America E Nasopharyngeal Cancer Drug Sales Price (USD/Pcs)
    Figure North America  Nasopharyngeal Cancer Drug Sales Market Share
    Figure Europe Capacity Overview
    Table Europe Supply, Import, Export and Consumption (K Pcs) of Nasopharyngeal Cancer Drug E
    Figure Europe E Nasopharyngeal Cancer Drug Sales Price (USD/Pcs)
    Figure Europe  Nasopharyngeal Cancer Drug Sales Market Share
    Figure China Capacity Overview
    Table China Supply, Import, Export and Consumption (K Pcs) of Nasopharyngeal Cancer Drug E
    Figure China E Nasopharyngeal Cancer Drug Sales Price (USD/Pcs)
    Figure China  Nasopharyngeal Cancer Drug Sales Market Share
    Figure Japan Capacity Overview
    Table Japan Supply, Import, Export and Consumption (K Pcs) of Nasopharyngeal Cancer Drug E
    Figure Japan E Nasopharyngeal Cancer Drug Sales Price (USD/Pcs)
    Figure Japan  Nasopharyngeal Cancer Drug Sales Market Share
    Figure Southeast Asia Capacity Overview
    Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Nasopharyngeal Cancer Drug E
    Figure Southeast Asia E Nasopharyngeal Cancer Drug Sales Price (USD/Pcs)
    Figure Southeast Asia  Nasopharyngeal Cancer Drug Sales Market Share
    Figure India Capacity Overview
    Table India Supply, Import, Export and Consumption (K Pcs) of Nasopharyngeal Cancer Drug E
    Figure India E Nasopharyngeal Cancer Drug Sales Price (USD/Pcs)
    Figure India  Nasopharyngeal Cancer Drug Sales Market Share
    Table Global E Nasopharyngeal Cancer Drug Sales (K Pcs) by Type
    Table Different Types Nasopharyngeal Cancer Drug Product Interview Price
    Table Global E Nasopharyngeal Cancer Drug Sales (K Pcs) by Application
    Table Different Application Nasopharyngeal Cancer Drug Product Interview Price
    Table Ambrx Inc Information List
    Table Product Overview
    Table  Ambrx Inc Nasopharyngeal Cancer Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure  Ambrx Inc Nasopharyngeal Cancer Drug Business Region Distribution
    Table arGEN-X BV Information List
    Table Product Overview
    Table  arGEN-X BV Nasopharyngeal Cancer Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure  arGEN-X BV Nasopharyngeal Cancer Drug Business Region Distribution
    Table Atara Biotherapeutics Inc Information List
    Table Product Overview
    Table  Atara Biotherapeutics Inc Nasopharyngeal Cancer Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure  Atara Biotherapeutics Inc Nasopharyngeal Cancer Drug Business Region Distribution
    Table AVEO Pharmaceuticals Inc Information List
    Table Product Overview
    Table  AVEO Pharmaceuticals Inc Nasopharyngeal Cancer Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure  AVEO Pharmaceuticals Inc Nasopharyngeal Cancer Drug Business Region Distribution
    Table BeiGene Ltd Information List
    Table Product Overview
    Table  BeiGene Ltd Nasopharyngeal Cancer Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure  BeiGene Ltd Nasopharyngeal Cancer Drug Business Region Distribution
    Table BioDiem Ltd Information List
    Table Product Overview
    Table  BioDiem Ltd Nasopharyngeal Cancer Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure  BioDiem Ltd Nasopharyngeal Cancer Drug Business Region Distribution
    Table Biomics Biotechnologies Co Ltd Information List
    Table Product Overview
    Table  Biomics Biotechnologies Co Ltd Nasopharyngeal Cancer Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure  Biomics Biotechnologies Co Ltd Nasopharyngeal Cancer Drug Business Region Distribution
    Table Bristol-Myers Squibb Company Information List
    Table Product Overview
    Table  Bristol-Myers Squibb Company Nasopharyngeal Cancer Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure  Bristol-Myers Squibb Company Nasopharyngeal Cancer Drug Business Region Distribution
    Table CBT Pharmaceuticals Inc Information List
    Table Product Overview
    Table  CBT Pharmaceuticals Inc Nasopharyngeal Cancer Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure  CBT Pharmaceuticals Inc Nasopharyngeal Cancer Drug Business Region Distribution
    Table Celgene Corp Information List
    Table Product Overview
    Table  Celgene Corp Nasopharyngeal Cancer Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure  Celgene Corp Nasopharyngeal Cancer Drug Business Region Distribution
    Table Cell Medica Ltd Information List
    Table F. Hoffmann-La Roche Ltd Information List
    Table GlaxoSmithKline Plc Information List
    Figure Global 2018-2025 Nasopharyngeal Cancer Drug Market Size (K Pcs) and Growth Rate Forecast
    Figure Global 2018-2025 Nasopharyngeal Cancer Drug Market Size (Million USD) and Growth Rate Forecast
    Figure Global 2018-2025 Nasopharyngeal Cancer Drug Sales Price (USD/Pcs) Forecast
    Figure North America 2018-2025 Nasopharyngeal Cancer Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure China 2018-2025 Nasopharyngeal Cancer Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure Europe 2018-2025 Nasopharyngeal Cancer Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure Southeast Asia 2018-2025 Nasopharyngeal Cancer Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure Japan 2018-2025 Nasopharyngeal Cancer Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure India 2018-2025 Nasopharyngeal Cancer Drug Consumption Volume (K Pcs) and Growth Rate Forecast
    Table Global Sales Volume (K Pcs) of Nasopharyngeal Cancer Drug by Type 2018-2025
    Table Global Consumption Volume (K Pcs) of Nasopharyngeal Cancer Drug by Application 2018-2025
    Table Traders or Distributors with Contact Information of Nasopharyngeal Cancer Drug by Region

Segments Analysis

By Product / Drug Type

• BGBA-317
  PI3K pathway inhibitor for advanced solid tumors

• CBT-501
  Immune-based oncology therapy candidate

• Apatinib
  VEGFR-2 targeted anti-angiogenic agent

• APG-1387
  IAP antagonist targeting apoptosis pathways

• ARGX-110
  Monoclonal antibody targeting CD70

• ATA-129
  EBV-specific T-cell immunotherapy

• Immune Checkpoint Inhibitors (Expanded Segment)
  PD-1 / PD-L1 and CTLA-4 targeted agents

• Conventional Chemotherapy (Added)
  Platinum-based and combination regimens

• Others

By Drug Class (New Segmentation)

• Targeted Therapy

• Immunotherapy (Checkpoint & Cell-based)

• Anti-angiogenic Agents

• Cytotoxic Chemotherapy

By Treatment Line (Added)

• First-line Therapy

• Second-line Therapy

• Refractory / Relapsed Treatment

By Application / Care Setting

• Hospital

• Clinic

• Others (Specialty oncology centers, academic hospitals)

Key Market Players

Major & Pipeline-Driven Manufacturers

• Bristol-Myers Squibb Company

• F. Hoffmann-La Roche Ltd

• GlaxoSmithKline Plc

• BeiGene Ltd

• Ambrx Inc

• arGEN-X BV

• Atara Biotherapeutics Inc

• AVEO Pharmaceuticals Inc

• Celgene Corp

• Cell Medica Ltd

Additional & Regional Participants (Expanded)

• Innovent Biologics

• Junshi Biosciences

• Hengrui Medicine

• Jiangsu Simcere Pharmaceutical

• Shanghai Henlius Biotech